VRPX Virpax: Accounting Value per Share

Graphic logo of Virpax Pharmaceuticals, Inc. (VRPX)

Geopolitical tensions and component import challenges are impacting the dynamics of Virpax Pharmaceuticals (VRPX), as clearly demonstrated by the book value per share chart. The value of -1.52 captures the current magnitude of the indicator. The development of safe nasal drug delivery systems reduces scientific risks, while future CNS patents will enable the company to exercise pricing power with insurers.

Virpax (VRPX): Share Book Value from 07/04/2022 to 04/13/2025

Virpax Pharmaceuticals Inc. - analytical breakdowns and key metrics (VRPX)

- price and consensus price forecast:
Price Chart Virpax|VRPX - Forecast Levels Chart
- market capitalization data:
Market Valuation Virpax Pharmaceuticals, Inc.|VRPX - Business Value
- book capitalization data:
Net Assets per Single Share Virpax Pharmaceuticals|VRPX - Net Asset Value|Market Capitalization to Book Value Ratio virpaxpharma.com|VRPX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Virpax Pharmaceuticals|VRPX - Long-Term Debt to Capital|Short-Term Debt to Equity Virpax|VRPX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Virpax Pharmaceuticals, Inc.|VRPX - Company Long-Term Liabilities|Company Short-Term Debts Virpax Pharmaceuticals
Fundamental company valuation:virpaxpharma.com - VRPX
Manufactured products of Virpax

For the biotech sector of Virpax Pharmaceuticals (VRPX), where liquidity shortage risks dominate, book value per share becomes a critical indicator of survival. This metric is calculated as the difference between all company assets and liabilities divided by the number of shares, demonstrating the real value of an investor's stake upon business liquidation. The trend of this indicator allows analysts to distinguish fundamental undervaluation from systemic capital depreciation.

Competitors of Virpax Pharmaceuticals (VRPX)

Net Assets per Single Share Alkermes Inc.|Avadel Corp (AVDL) - Share Book Value|Accounting Value per Share Atai Life Sciences N.V.|GHRS (ghres.com) - Equity per Share|Net Assets per Single Share MindMed MNMD|Share Book Value COMPASS Pathways PLC|LB Pharma (LBRX) - Book Value per Share|Accounting Value of a Share Bright Minds Corp (DRUG)|Book Value per Share VNDA (Vanda Pharmaceuticals)|Cybin Inc - Book Value per Share|Net Assets per Single Share Alto Neuroscience (ANRO)|NRXP: Accounting Value of a Share|CING (cingulate.com) - Net Assets per Single Share|silopharma.com (SILO) - Accounting Value per Share|CPHI (China Pharma Holdings Inc.) - Book Value per Share|Book Value per Share Clearmind Medicine, Inc. (CMND)|Psyence Biomedical (PBM) - Accounting Value per Share|Accounting Value of a Share SPRC (SciSparc Ltd.)|Seelos Therapeutics, Inc (SEEL) - Net Assets per Single Share|Karuna Pharma - Share Book Value